Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Innoviva, Inc.(INVA) | 2,816,022 | 2,816,022 | 0 | $56.57M | $51.39M | 28.49% | -$5.18M |
| Neurocrine Biosciences, Inc.(NBIX) | 303,151 | 303,151 | 0 | $38.10M | $42.56M | 23.59% | +$4.45M |
| Cytokinetics, Incorporated(CYTK) | 588,357 | 588,357 | 0 | $19.44M | $32.34M | 17.93% | +$12.90M |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 15,919,435 | 15,919,435 | 0 | $11.42M | $20.85M | 11.56% | +$9.44M |
| Amarin Corp PlcADR | 1,242,527 | 1,242,527 | 0 | $20.15M | $20.35M | 11.28% | +$198.8K |
| Lantheus Holdings, Inc.(LNTH) | 96,251 | 181,450 | +85,199 | $7.88M | $9.31M | 5.16% | +$1.43M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 0 | 4,190 | +4,190 | $0 | $2.36M | 1.31% | +$2.36M |
| Vor Biopharma Inc.(VOR) | 0 | 25,399 | +25,399 | $0 | $1.24M | 0.69% | +$1.24M |
| Vor Biopharma Inc.(VOR) | 508,016 | 0 | -508,016 | $823.0K | $0 | — | -$823.0K |